AllNewsVideos'Us Drug Prices' - 63 News Result(s)With 2024 In Mind, Joe Biden's Big Move To Lower Drug PricesWorld News | Agence France-Presse | Wednesday August 30, 2023 US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court. www.ndtv.comLupin Gains On Receiving US FDA Nod To Launch Drug For OnychomycosisBusiness | Edited by Abhishek Vasudev | Tuesday July 13, 2021 Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA). www.ndtv.com/businessCadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes DiseaseBusiness | Edited by Peter Noronha | Thursday February 25, 2021 Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease www.ndtv.com/businessSputnik V Firm Says Its COVID-19 Vaccine Cheaper Than Pfizer, ModernaWorld News | ANI | Sunday November 22, 2020 The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account on Sunday. www.ndtv.comDr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In USBusiness | Edited by Sandeep Singh | Friday September 18, 2020 The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent. www.ndtv.com/businessTrump Says He Has Signed New Executive Order To Lower Drug PricesWorld News | Reuters | Monday September 14, 2020 US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations. www.ndtv.comUS Group Raises Pricing Recommendation For Gilead's Remdesivir In COVIDWorld News | Reuters | Thursday June 25, 2020 Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its prior recommendation of around $4,500. www.ndtv.comCipla Shares Fall 6% After US Regulator's Warning Letter On Goa FacilityBusiness | Edited by Sandeep Singh | Wednesday February 26, 2020 Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations. www.ndtv.com/businessNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessWhy Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% TodayBusiness | NDTV Profit Team | Wednesday July 17, 2019 US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records. www.ndtv.com/businessDonald Trump Promises To Reduce US Drug Prices To World's LowestWorld News | Agence France-Presse | Saturday July 6, 2019 US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world. www.ndtv.comLawsuit Against Aurobindo Pharma, Other Drug Makers Filed In USBusiness | Indo-Asian News Service | Tuesday May 14, 2019 Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results. www.ndtv.com/businessAurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US AcquisitionBusiness | NDTV Profit Team | Thursday September 6, 2018 Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019... www.ndtv.com/businessAfter Donald Trump Tweet, Drug Company Pfizer Reverses Price HikesWorld News | Reuters | Thursday July 12, 2018 Pfizer has reversed price increases on some drugs following White House pressure and the US drugmaker on Wednesday pledged to decide soon whether to sell its consumer drugs business. www.ndtv.comTrump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price HikesWorld News | Reuters | Tuesday July 10, 2018 US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response. www.ndtv.comMore News »'Us Drug Prices' - 2 Video Result(s)Prannoy Roy, Investor Ruchir Sharma Discuss Top 10 Trends of 2022Jan 8, 202253:22Oxford Vaccine At Rs 1,000 If Centre Allows Us To Sell: Adar PoonawallaJan 4, 20211:32'Us Drug Prices' - 63 News Result(s)With 2024 In Mind, Joe Biden's Big Move To Lower Drug PricesWorld News | Agence France-Presse | Wednesday August 30, 2023 US President Joe Biden, who is campaigning for reelection with a heavy focus on easing voters' financial woes, on Tuesday launched a bid to lower the cost of certain prescription drugs -- a move Big Pharma pledged to continue battling in court. www.ndtv.comLupin Gains On Receiving US FDA Nod To Launch Drug For OnychomycosisBusiness | Edited by Abhishek Vasudev | Tuesday July 13, 2021 Lupin received approval to launch Tavaborole Topical Solution, 5 per cent in United States (US) from the United States Food and Drug Administration (FDA). www.ndtv.com/businessCadila Healthcare Gains Over 2% After Unit Buys Drug For Menkes DiseaseBusiness | Edited by Peter Noronha | Thursday February 25, 2021 Cadila Healthcare said that its US subsidiary has acquired an experimental drug from Cyprium for treating Menkes disease, which is a rare recessive pediatric disease www.ndtv.com/businessSputnik V Firm Says Its COVID-19 Vaccine Cheaper Than Pfizer, ModernaWorld News | ANI | Sunday November 22, 2020 The price per dose of the Russian coronavirus vaccine Sputnik V will be much lower than that of the vaccines of US drug giants Pfizer and Moderna, said the Russian vaccine's official Twitter account on Sunday. www.ndtv.comDr Reddy's Soars To Record High After Drug Maker Settles Patent Litigation In USBusiness | Edited by Sandeep Singh | Friday September 18, 2020 The Nifty Pharma index - which captures the performance of 10 drug makers in the country, including Dr Reddy's, Lupin, Cipla and Sun Pharma - jumped as much as 3.66 per cent. www.ndtv.com/businessTrump Says He Has Signed New Executive Order To Lower Drug PricesWorld News | Reuters | Monday September 14, 2020 US President Donald Trump said on Sunday he had signed a new executive order aimed at lowering drug prices in the United States by linking them to those of other nations. www.ndtv.comUS Group Raises Pricing Recommendation For Gilead's Remdesivir In COVIDWorld News | Reuters | Thursday June 25, 2020 Gilead Sciences Inc's antiviral remdesivir could be priced up to $5,080 per course based on benefits shown in COVID-19 patients, a U.S. drug pricing research group suggested on Wednesday, above its prior recommendation of around $4,500. www.ndtv.comCipla Shares Fall 6% After US Regulator's Warning Letter On Goa FacilityBusiness | Edited by Sandeep Singh | Wednesday February 26, 2020 Cipla Share Price: Cipla said it will work closely with the US Food and Drug Administration (FDA) to comprehensively address all the observations. www.ndtv.com/businessNovartis Sickle-Cell Drug Gets US ApprovalBusiness | Reuters | Saturday November 16, 2019 The drug will be priced between $84,852 and $113,136 per year for most patients, who will typically infuse themselves with between three and four vials each month, Novartis said. www.ndtv.com/businessWhy Shares Of This Bengaluru-Based Drug Maker Plunged Over 8% TodayBusiness | NDTV Profit Team | Wednesday July 17, 2019 US FDA had inspected Strides Pharma's drug manufacturing facility in Puducherry from January 28 to February 5, 2019 and said that the company was caught trying to dispose quality-control records. www.ndtv.com/businessDonald Trump Promises To Reduce US Drug Prices To World's LowestWorld News | Agence France-Presse | Saturday July 6, 2019 US President Donald Trump on Friday said his administration is working on an executive order to reduce US drug prices to match the lowest in the world. www.ndtv.comLawsuit Against Aurobindo Pharma, Other Drug Makers Filed In USBusiness | Indo-Asian News Service | Tuesday May 14, 2019 Aurobindo said it does not anticipate that these matters will have a material impact on the its operations or business results. www.ndtv.com/businessAurobindo Pharma Shares Jump 6% After Drug Maker Announces $900-Million US AcquisitionBusiness | NDTV Profit Team | Thursday September 6, 2018 Aurobindo Pharma share price jumped more than 6 per cent in intraday trade with large volumes after the announcement. Aurobindo Pharma said it will acquire the dermatology and oral solids businesses from Sandoz Inc, USA, a unit of Swiss pharmaceutical company Novartis. Aurobindo Pharma said the deal worth $900 million was expected to close in 2019... www.ndtv.com/businessAfter Donald Trump Tweet, Drug Company Pfizer Reverses Price HikesWorld News | Reuters | Thursday July 12, 2018 Pfizer has reversed price increases on some drugs following White House pressure and the US drugmaker on Wednesday pledged to decide soon whether to sell its consumer drugs business. www.ndtv.comTrump Says Drugmaker Pfizer Should Be "Ashamed" For Drug Price HikesWorld News | Reuters | Tuesday July 10, 2018 US President Donald Trump on Monday took aim at Pfizer Inc and other US drugmakers after they raised prices on some of their medicines on July 1, saying his administration would act in response. www.ndtv.comMore News »'Us Drug Prices' - 2 Video Result(s)Prannoy Roy, Investor Ruchir Sharma Discuss Top 10 Trends of 2022Jan 8, 202253:22Oxford Vaccine At Rs 1,000 If Centre Allows Us To Sell: Adar PoonawallaJan 4, 20211:32Your search did not match any documentsA few suggestionsMake sure all words are spelled correctlyTry different keywordsTry more general keywordsCheck the NDTV Archives:https://archives.ndtv.com